SCHEMBL13744682

SCHEMBL13744682

CCSc1cc(C)nc(N)n1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.59
HSP90AB1 P08238 3/20 0.57
LMNA P02545 4/20 0.53
NPC1 O15118 2/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
MAPT P10636 1/20 0.53
GAA P10253 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
KMT2A Q03164 1/20 0.47
HSP90AA1 P07900 3/20 0.46
POLB P06746 1/20 0.42
TLR8 Q9NR97 1/20 0.42
NUDT1 P36639 1/20 0.40
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ADORA2A P29274 1/20 0.38
ADORA1 P30542 1/20 0.38
KDM4E B2RXH2 1/20 0.38
CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7568606 0.82 HSP90AB1 (0.55) TSHRHSP90AB1LMNANPC1L3MBTL1
SCHEMBL7568049 0.82 HSP90AB1 (0.55) TSHRHSP90AB1LMNANPC1L3MBTL1
SCHEMBL741180 0.79 HSP90AB1 (0.50) TSHRHSP90AB1LMNANPC1L3MBTL1
SCHEMBL28486478 0.79 HSP90AB1 (0.50) TSHRHSP90AB1LMNANPC1L3MBTL1
SCHEMBL18001725 0.78 LMNA (0.54) LMNAL3MBTL1GAAKMT2AHSP90AA1
SCHEMBL6829600 0.77 HSP90AB1 (0.49) TSHRHSP90AB1LMNANPC1L3MBTL1
SCHEMBL12892260 0.76 LMNA (0.38) TSHRHSP90AB1LMNANPC1L3MBTL1
SCHEMBL11640161 0.76 TSHR (1.00) TSHRHSP90AB1LMNAMAPTGAA
SCHEMBL151114 0.72
SCHEMBL8874397 0.71 KMT2A (0.40) TSHRHSP90AB1LMNANPC1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090215777-A1 Pyrimidine Derivatives As HSP90 Inhibitors ASTEX THERAPEUTICS LTD. (GB) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215777-A1 Pyrimidine Derivatives As HSP90 Inhibitors HSP90AB1, HSP90AB2P, HSP90B1 TSHR 2843/4885HSP90AB1 1/4885LMNA 4191/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.